These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15193957)

  • 1. Cannabinoid receptor-independent suppression of the superoxide generation of human neutrophils (PMN) by CP55 940, but not by anandamide.
    Kraft B; Wintersberger W; Kress HG
    Life Sci; 2004 Jul; 75(8):969-77. PubMed ID: 15193957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect CB2 receptor and mediator-dependent stimulation of human whole-blood neutrophils by exogenous and endogenous cannabinoids.
    Kraft B; Kress HG
    J Pharmacol Exp Ther; 2005 Nov; 315(2):641-7. PubMed ID: 16055676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
    Houser SJ; Eads M; Embrey JP; Welch SP
    Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems.
    Welch SP
    Drug Alcohol Depend; 1997 Apr; 45(1-2):39-45. PubMed ID: 9179505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.
    O'Sullivan SE; Kendall DA; Randall MD
    Eur J Pharmacol; 2005 Jan; 507(1-3):211-21. PubMed ID: 15659311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
    Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
    J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship.
    Molderings GJ; Likungu J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):157-64. PubMed ID: 10494885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW
    Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves.
    Spicuzza L; Haddad EB; Birrell M; Ling A; Clarke D; Venkatesan P; Barnes PJ; Belvisi MG
    Br J Pharmacol; 2000 Aug; 130(7):1720-6. PubMed ID: 10928980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB; Compton DR; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids and the human uterus during pregnancy.
    Dennedy MC; Friel AM; Houlihan DD; Broderick VM; Smith T; Morrison JJ
    Am J Obstet Gynecol; 2004 Jan; 190(1):2-9; discussion 3A. PubMed ID: 14749627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
    Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
    Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
    Smith PB; Compton DR; Welch SP; Razdan RK; Mechoulam R; Martin BR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):219-27. PubMed ID: 8035318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The orphan receptor GPR55 is a novel cannabinoid receptor.
    Ryberg E; Larsson N; Sjögren S; Hjorth S; Hermansson NO; Leonova J; Elebring T; Nilsson K; Drmota T; Greasley PJ
    Br J Pharmacol; 2007 Dec; 152(7):1092-101. PubMed ID: 17876302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus.
    Gamber KM; Macarthur H; Westfall TC
    Neuropharmacology; 2005 Oct; 49(5):646-52. PubMed ID: 15949823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cannabinoids, cannabinoid receptor and immune response].
    Yan MS; Lian ML; Huang JS
    Sheng Li Ke Xue Jin Zhan; 2000 Jul; 31(3):261-4. PubMed ID: 12545719
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
    Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.
    Ford WR; Honan SA; White R; Hiley CR
    Br J Pharmacol; 2002 Mar; 135(5):1191-8. PubMed ID: 11877326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.